Onesource Specialty Pharma Limited - Company overview

Stelis Biopharma is a listed public limited company, first registered with ROC Mumbai Ii on 12 June 2007.

2007-06-12 Thane, Maharashtra Active Listed Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹1000+ Cr
▲ 730.2%
FY 2025
PROFIT / LOSS
Loss · ₹10–25 Cr
▲ 95.4%
FY 2025
EBITDA
₹100–500 Cr
▲ 522.9%
FY 2025
NET WORTH
₹1000+ Cr
▲ 1386.1%
FY 2025
TOTAL ASSETS
₹1000+ Cr
▲ 477.0%
FY 2025
EMPLOYEE COUNT
551–560
OPEN CHARGES
20
-
PAID-UP CAPITAL
11.47 cr
AUTHORISED CAPITAL
15.00 cr
COMPANY AGE
19 Years 5 Months
since 2007-06-12
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-09-22
ACTIVE GST
1
Updated: 2025-03-11 14:39:10
TOTAL MONEY RAISED
₹1000+ Cr
SATISFIED CHARGES
12
1,250.24 cr

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Stelis Biopharma covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Low risk
81/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (81), financial health (70), director (85) and company-foundation signals.
  • Operating for 19+ years.
Compliance Score Low risk
81/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2025 - slightly behind.
Financial Health Score Moderate
70/100
Profitability, leverage and liquidity from filed statements.
  • Loss-making in FY 2025.
  • Positive net worth.
Director Risk Score Low risk
85/100
Board strength, DIN status and churn.
  • 12 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Stelis Biopharma Company identity, industry, contact, and registration details from MCA and company records.

Stelis Biopharma is a listed public limited company, first registered with ROC Mumbai Ii on 12 June 2007. Its registered office is at Unit No. 902, Cyber One, Thane, Maharashtra. Earlier names on record include Inbiopro Solutions Private Limited and Stelis Biopharma Private Limited.

Its filings describe the main line of business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, which made up 100% of turnover.

It has 12 directors: Bharat Dhirajlal Shah, Anurag Bhagania, Allada Trisha and 9 others. The longest-serving is Arun Kumar Pillai, on the board since 2021; the most recent to join is Colin Bond Michael, appointed in June 2025. Neeraj Sharma is the managing director. 32 former directors are on record; the most recent to leave was Yogita Chetan Hatangadi in January 2024. Between them, the directors also sit on the boards of 8 other companies, including Atlas Documentary Facilitators Company Private Limited and Credila Financial Services Limited.

Paid-up capital stands at ₹11.47 crore out of ₹15 crore authorised. The last AGM on record was on 22 September 2025, for accounts made up to 31 March 2025. 20 charges (secured loans) are still open, with Yes Bank Limited among the lenders, and 12 more have been paid off.

Chemicals •••••••• •••••••• ••••••••
  • Location Unit No. 902, Cyber One, Thane, Maharashtra - 400703
  • Website stelis.com
Name History
Legal NameOnesource Specialty Pharma Limited
CIN / LLPINL74140MH2007PLC432497
Company No.432497
ClassificationPublic Limited Indian Non-Government Company
Incorporation Date2007-06-12
Date of AGM2025-09-22
Date of Balance Sheet2025-03-31
Listing StatusListed
ROC CodeRoc Mumbai Ii
Credit RatingA+ (Icra)
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Stelis Biopharma (12) Current board members from MCA filings, including designation and appointment details.

B
Director | Since 2024-07-26 | DIN: 00136969
A
CFO | Since 2024-07-04 | DIN: 02299791
A
Allada Trisha
Company Secretary | Since 2023-04-20
R
Director | Since 2024-05-17 | DIN: 10593871
N
Managing Director | Since 2024-03-01 | DIN: 09402652
C
Director | Since 2025-02-27 | DIN: 10109819

Financial Performance of Stelis Biopharma Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2025
Revenue ₹1000+ Cr ▲ 730.2%
P&L Loss · ₹10–25 Cr ▲ 95.4%
EBITDA ₹100–500 Cr ▲ 522.9%
Net worth ₹1000+ Cr ▲ 1386.1%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Stelis Biopharma Open and satisfied charges registered against the company with MCA.

Others : 1,828.07 cr
Yes Bank Limited : 100.00 cr
Open Charges: 20 Satisfied Charges: 12
Open -
Satisfied 1,250.24 cr
LenderAmountStatus
Others
Creation Date: 12 Jun 2026
310.58 cr Open
Others
Creation Date: 28 Jan 2026
75.00 cr Open
Yes Bank Limited
Creation Date: 27 Dec 2025
100.00 cr Open

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
ManufacturingChemical and chemical products, pharmaceuticals, medicinal chemical and botanical products100

Companies With Common Directors Of Stelis Biopharma Other companies that share directors with this entity, based on MCA and compliance network data.

Financial Ratios of Stelis Biopharma Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

10 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Stelis Biopharma Ownership and contribution detail from filings. Full breakdown unlocks with your report.

9 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Stelis Biopharma EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Stelis Biopharma GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Stelis Biopharma Ratings, court records, and regulatory alerts. Full risk detail unlocks with your report.

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

Rating history Court and tribunal cases Regulatory alerts Director-linked violations

Credit ratings, litigation, and regulatory alerts require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Stelis Biopharma MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Stelis Biopharma Parent, subsidiary, and related group entities. Full ownership map unlocks with your report.

1 subsidiary on record

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

Parent company Subsidiaries and ownership Associates and joint ventures Entity investments

Corporate group structure requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Stelis Biopharma Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Stelis Biopharma Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Stelis Biopharma?
MCA does not publish an "owner" field. Stelis Biopharma is run by its directors, Bharat Dhirajlal Shah, Anurag Bhagania, Allada Trisha and nine others, with Neeraj Sharma as managing director. It is owned by its shareholders, and the promoter holding is in the shareholding pattern it files with the stock exchanges.
Who are the current board members and directors of Stelis Biopharma?
Stelis Biopharma has 12 current directors: Bharat Dhirajlal Shah (since July 2024), Anurag Bhagania (since July 2024), Allada Trisha (since April 2023), Rashmi Harshadrai Barbhaiya (since May 2024), Neeraj Sharma (since March 2024) and Claudio Dr. Albrecht (since February 2025), plus 6 more. Neeraj Sharma is the managing director.
What is CIN of Stelis Biopharma?
The CIN of Stelis Biopharma is L74140MH2007PLC432497. Reading it left to right: L means it is listed, 74140 is the industry code it registered under, MH is Maharashtra, 2007 is the year it was registered, PLC is the company type and 432497 is its registration number.
When was Stelis Biopharma incorporated?
Stelis Biopharma was incorporated on 12 June 2007 with ROC Mumbai Ii. That makes it about 19 years old.
What is the registered address of Stelis Biopharma?
The registered office on MCA records is Unit No. 902, Cyber One, Thane, Maharashtra - 400703.
What is the current status of Stelis Biopharma?
MCA shows Stelis Biopharma as Active, and its last AGM on record was in September 2025.
What is the contact number or email for Stelis Biopharma?
You can post to its registered office at Unit No. 902, Cyber One, Thane, Maharashtra - 400703 and use its website, https://stelis.com.
What industry or business activity is Stelis Biopharma associated with?
Its MCA filings list the main business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products (100% of turnover).
What is paid-up capital and authorised share capital of Stelis Biopharma?
Paid-up capital is ₹11.47 crore and authorised capital is ₹15 crore, so about 76% of the authorised amount has been issued.
When did Stelis Biopharma last file accounts and hold an AGM?
The last AGM on record was on 22 September 2025, and the latest balance sheet is for the year ending 31 March 2025.
Where can I see charges and lenders for Stelis Biopharma?
20 charges against Stelis Biopharma are still open and 12 have been satisfied. Lenders named in the filings include Yes Bank Limited.
Have any directors left Stelis Biopharma?
Yes, 32 former directors are on record. The most recent to leave were Yogita Chetan Hatangadi (January 2024), Bhushan Sudhir Bopardikar (September 2023) and Rajashri Santosh Kumar Ojha (August 2023).
Which companies share directors with Stelis Biopharma?
8 companies share directors with Stelis Biopharma. Among them are Atlas Documentary Facilitators Company Private Limited, Credila Financial Services Limited, Hdfc Ergo Health Insurance Limited and 5 more.
What is the turnover or revenue of Stelis Biopharma?
Based on filed financial statements, the revenue of Stelis Biopharma for FY 2025 was in the ₹1000+ Cr range. That is up 730.2% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Stelis Biopharma?
For FY 2025, the net worth of Stelis Biopharma was in the ₹1000+ Cr range.
How can I get the financial details of Stelis Biopharma?
The latest accounts on record are for FY 2025. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Stelis Biopharma?
The website on record for Stelis Biopharma is https://stelis.com.
Which company owns stelis.com?
stelis.com is the website listed for Onesource Specialty Pharma Limited in its company records.
Is Stelis Biopharma registered with any stock exchange in India?
MCA marks it as a listed company.
Stelis Biopharma - is it listed or unlisted?
Stelis Biopharma is a listed company, and its CIN starts with L.
What is the ROC code of Stelis Biopharma?
Stelis Biopharma is registered with ROC Mumbai Ii.
What is the company classification of Stelis Biopharma?
MCA classifies Stelis Biopharma as: Public Limited Indian Non-Government Company.
Does Stelis Biopharma have subsidiaries?
Yes, one subsidiary is on record for Stelis Biopharma.
Does Stelis Biopharma have GST registrations on file?
Yes, one active GST registration is linked to Stelis Biopharma.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.